Category: Venture Capital

Analysis, BioTech, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Abbott Shows Strong Growth in Emerging Markets

Abbott Laboratories ABT reported solid second-quarter performance that underscored the strength of its presence in emerging markets, where robust growth continues. While second-quarter results have not spurred a change in projections for the rest of this year or 2014, we may see $40 per share, which was primarily driven by a lower cost of equity assumption. Considering the breadth of new Abbott’s remaining businesses, the … Continue reading Abbott Shows Strong Growth in Emerging Markets

Adam KeintzelLeave a comment
FB Nasdaq FB Facebook
Analysis, BioTech, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

EXC May Need to Watch Obama Administration

Exelon is the largest U.S. competitive power generator with roughly 35 gigawatts of power generation, including the nation’s largest nuclear fleet with 19 GW of capacity, as a result of its all-stock merger with Constellation Energy, which closed in 2012. Exelon is also the nation’s secondlargest regulated distributor of electricity and gas (6.6 million customers) and one of the largest retail energy suppliers in the … Continue reading EXC May Need to Watch Obama Administration

Ryan HoltzLeave a comment
FB Nasdaq FB Facebook
Analysis, BioTech, Commodities, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Thankfully, BG’s Earnings Report Uneventful

BG Group BG. reported largely uneventful first-quarter results with most key metrics in line with previous guidance, which provided a welcome respite from previous quarters’ downward production guidance revisions and budget overruns. Total operating profit fell to $2.1 billion from $2.3 billion the year before as lower production and higher operating costs and depreciation offset the benefit of higher realized gas prices. Production fell to … Continue reading Thankfully, BG’s Earnings Report Uneventful

John MeadyLeave a comment
FB Nasdaq FB Facebook
Analysis, BioTech, Commodities, Diversified Tech, Finance, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

RSA Releases 1Q Management Statement

RSA Insurance Group RSA released its first-quarter interim management statement, which contained a limited amount of information about its progress so far this year. Reported written premium growth was 7% across the group, due to a combination of acquired premiums and the positive impact of rate gains due to the improving insurance pricing market. The strength was driven, in particular, by growth in emerging markets … Continue reading RSA Releases 1Q Management Statement

John MeadyLeave a comment
FB Nasdaq FB Facebook
Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

BSkyB Reports Solid Fiscal Q3 Results; Maintaining Our Fair Value Estimate

British Sky Broadcasting BSYBY , known as BSkyB, reported solid fiscal third-quarter results. Revenue increased 7.8% year over year, bringing the nine-month result up 6%, spot on with our full-year projection. We are maintaining our fair value estimate and moat rating. The firm’s growth is being driven primarily by subscriber additions, particularly in its communication business where its broadband base improved 13.6% to 4.4 million, … Continue reading BSkyB Reports Solid Fiscal Q3 Results; Maintaining Our Fair Value Estimate

John MeadyLeave a comment
FB Nasdaq FB Facebook
Analysis, BioTech, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Weak Discretionary Spending in Europe Keeps Capgemini’s Growth in Check

Capgemini CAP reported first-quarter results that were largely in line with our expectations, and we are maintaining our EUR 39 fair value estimate and narrow moat rating for the company. Capgemini’s first-quarter revenue fell 1.7% to EUR 2.5 billion as the company’s cyclical businesses reported weak numbers amid sluggish economic conditions in Europe. The company’s results would have been worse if not for a stable … Continue reading Weak Discretionary Spending in Europe Keeps Capgemini’s Growth in Check

John MeadyLeave a comment